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Phenazines are a class of redox-active molecules produced by
diverse bacteria and archaea.Many of the biological functions of
phenazines, such as mediating signaling, iron acquisition, and
redox homeostasis, derive from their redox activity. Although
prior studies have focused on extracellular phenazine oxidation
by oxygen and iron, here we report a search for reductants and
catalysts of intracellular phenazine reduction in Pseudomonas
aeruginosa. Enzymatic assays in cell-free lysate, together with
crude fractionation and chemical inhibition, indicate that
P. aeruginosa contains multiple enzymes that catalyze the
reduction of the endogenous phenazines pyocyanin and phena-
zine-1-carboxylic acid in both cytosolic and membrane frac-
tions. We used chemical inhibitors to target general enzyme
classes and found that an inhibitor of flavoproteins and heme-
containing proteins, diphenyleneiodonium, effectively inhib-
ited phenazine reduction in vitro, suggesting that most phena-
zine reduction derives from these enzymes. Using natively
purified proteins, we demonstrate that the pyruvate and -ke-
toglutarate dehydrogenase complexes directly catalyze phena-
zine reduction with pyruvate or -ketoglutarate as electron
donors. Both complexes transfer electrons to phenazines
through the common subunit dihydrolipoamide dehydroge-
nase, a flavoprotein encoded by the gene lpdG. Although we
were unable to co-crystallize LpdG with an endogenous phena-
zine, we report its X-ray crystal structure in the apo-form (refined
to 1.35Å), bound toNAD (1.45Å), andbound toNADH(1.79Å).
In contrast to the notion that phenazines support intracellular
redox homeostasis by oxidizing NADH, our work suggests that
phenazinesmay substitute forNAD in LpdG and other enzymes,
achieving the same end by a differentmechanism.
Over a century ago, Pseudomonas aeruginosa was identified
as the source of a blue pigment observed in infectedwounds (1).
This pigment, a phenazine derivative known as pyocyanin (Fig.
1), was the first natural organic molecule shown to undergo
one-electron reduction (2–4). This distinctive property
inspired early studies into bacterial respiration. As early as
1931, Friedheim andMichaelis (5, 6) demonstrated that pyocy-
anin stimulates oxygen consumption and carbon dioxide pro-
duction in both P. aeruginosa (5) and human tissue (6), and so
initially pyocyaninwas considered an accessory respiratory pig-
ment analogous to quinones (5). This interpretation predated
an understanding of the electron transport chain, and today
pyocyanin is understood to alter redox homeostasis more gen-
erally (7, 8), althoughmethanophenazine can substitute for qui-
nones in the electron transport chains of certain methanogenic
archaea (9). Later researchers recognized that reduced pyocya-
nin and other phenazines react with molecular oxygen to form
toxic superoxide radicals (10). Phenazines also poison cells by
oxidizing iron-sulfur clusters (11), short-circuiting electron
transfer (12), covalently modifying proteins (13), and interca-
lating into DNA (14). This broad spectrum of toxicity became
the focus of phenazine research for several decades, and so
today phenazines are best known as antibiotics and virulence
factors.
Our interest in phenazines stems from the discovery that the
P. aeruginosa phenazines can reduce extracellularminerals (15,
16). Rather than merely inhibiting the growth of competing
organisms, we hypothesized that phenazine “antibiotics” could
directly benefit P. aeruginosa by promoting iron acquisition
and redox homeostasis (17, 18). This hypothesis has motivated
several experiments that illustrate physiological functions for
the endogenous phenazines of P. aeruginosa. We previously
showed that phenazine redox cycling promotes anaerobic sur-
vival on glucose (19, 20). Although P. aeruginosa does not fer-
ment glucose, phenazines serve as an electron acceptor that
enables glucose oxidation to acetate with concomitant ATP
synthesis (20). We also showed that phenazines, by acting as
electron shuttles, expand the habitable zone of colony biofilms
into the anoxic portion (8). These findings paint a nuanced view
where phenazines are multifunctional molecules, in some con-
texts possessing antibiotic activity and in others supporting
redox homeostasis or iron acquisition.
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In addition to pyocyanin, P. aeruginosa synthesizes at least
six other phenazine derivatives. The precursormolecule, phen-
azine-1-carboxylic acid (PCA)4 (Fig. 1), is synthesized from
chorismic acid by enzymes encoded in the homologous phzAB-
CDEFG1 and phzABCDEFG2 operons (21, 22). Additional
enzymes catalyze structural modifications of PCA to pyocya-
nin, phenazine-1-hydroxide, and phenazine-1-carboxamide
(23). Other endogenous P. aeruginosa phenazines have been
observed with amination (24) and sulfonation (25) modifica-
tions, although the pathways for these modifications are
unknown. Beyond P. aeruginosa, over 180 naturally occurring
phenazines have been described in the literature from a variety
of bacteria and archaea (Dictionary ofNatural Products, Chem-
netbase). This diverse array of structurally similar molecules
suggests particular phenazinesmight be tuned for certain func-
tions or properties. In support of this interpretation, the endog-
enous P. aeruginosa phenazines have different pH-dependent
solubilities, toxicities, and reactivities toward oxygen and iron
(16, 27).
Despite their structural diversity, the key biological functions
of phenazines, be it promoting anaerobic energy generation or
facilitating iron acquisition, derive from their redox activity.
The environmentally relevant extracellular oxidants,molecular
oxygen and ferric iron, are well characterized (16). In stark con-
trast, there is a dearth of information about biologically cata-
lyzed phenazine reduction. Although pyocyanin and PCA are
known to oxidize the electron donors NAD(P)H, dihydrolipo-
amide, and glutathione in vitro (15, 28), it is unknown whether
this is relevant in vivo or whether it is enzymatically catalyzed.
To address this unknown, previous work in our laboratory
attempted to identify phenazine reductases by screening trans-
posonmutants (29, 30).Mutants in glycerol-3-phosphate dehy-
drogenase and the cytochrome bc1 complex were found to be
deficient in pyocyanin reduction (29), but these mutants are
generally unhealthy and carry a number of pleiotropic effects
(29), rendering it impossible to ascribe pyocyanin reduction to
these proteins from the physiological data alone.
As an alternative to our prior genetic screens, in this studywe
used a biochemical approach to identify P. aeruginosa enzymes
with endogenous phenazine reductase activity. Our results sug-
gest that P. aeruginosamight not express an enzyme evolved to
specifically reduce phenazines; rather, our findings implicate
flavoproteins and/or heme-containing proteins as important
nonspecific catalysts for phenazine reduction. Illustrating this
principle, we identified and characterized the pyruvate and
-ketoglutarate dehydrogenase complexes as models for flavo-
protein-mediated phenazine reduction. Our data indicate that
under energy-limited anoxic conditions, phenazine substitu-
tion for NAD in these enzymes might contribute to the main-
tenance of intracellular redox homeostasis.
Results
Phenazine Reduction Is Catalyzed by Cell Lysate—We first
asked whether P. aeruginosa produces enzymes that catalyze
phenazine reduction. We focused on PCA (Fig. 1) because it is
the precursor for all biological phenazines in P. aeruginosa (23),
and it promotes anaerobic energy generation by redox cycling
(19, 20). It conveniently undergoes a color change to bright
yellow after reduction (31), enabling a colorimetric detection of
PCA reduction. To avoid re-oxidation by atmospheric oxygen,
we monitored PCA reduction using a plate reader housed
within an anaerobic chamber. Among the many possible intra-
cellular electron carriers, we tested NADH, NADPH, and glu-
tathione as electron donors that are important determinants of
the intracellular redox state (7, 32). Compared with pyocyanin,
PCA reacts relatively slowly with these donors, minimizing the
risk of misinterpreting non-enzymatic reduction for enzyme
activity. Because phenazines alter the metabolic flux of P.
aeruginosa (7, 20), we reasoned that intermediates of central
metabolismmight also serve as electron donors, and so we also
tested pyruvate, citrate, isocitrate, -ketoglutarate, succinate,
and malate. We prepared cell lysate from late-exponential
phase cultures grownon succinate, a preferred carbon source of
P. aeruginosa (33). Because phenazines induce a transcriptional
response in P. aeruginosa (34), and so may regulate the activity
of their endogenous reductases, we harvested the cultures sev-
eral hours after the onset of phenazine production as indicated
by the blue color of pyocyanin.
In the absence of cell lysate, PCA did not react with the
organic acidmetabolic intermediates, and it reacted only slowly
with NADH, NADPH, and glutathione (Fig. 2). Similarly, in the
absence of an exogenous electron donor, cell lysate slowly
reduced PCA over time (Fig. 2), likely deriving some reducing
equivalents frommetabolites already present within the lysate.
Relative to lysate or electron donor alone, lysate rapidly
reduced PCA when supplemented with NADH, NADPH, cit-
rate, isocitrate, pyruvate, or -ketoglutarate (Fig. 2). Glutathi-
one slightly increased the rate of PCA reduction, whereas
malate and succinate had no stimulatory effect when added to
lysate (Fig. 2). Boiling the cell lysate beforehand effectively elim-
inated PCA reduction even with the addition of exogenous
4 The abbreviations used are: PCA, phenazine-1-carboxylic acid; TPP, thia-
mine pyrophosphate; DLDH, dihydrolipoamide dehydrogenase.
FIGURE 1. Chemical structures and redox chemistry of the redox-active
substrates employed in this study.
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electron donors (Fig. 2), demonstrating that the lysate catalyzed
reduction rather than indirectly accelerating reduction through
a change in ionic strength or pH. Additionally, we found that
adding boiled lysate to un-boiled lysate could further accelerate
reduction with pyruvate and -ketoglutarate (Fig. 2), suggest-
ing the presence of additional cofactors or substrates in cell
lysate that are required for PCA reduction. Together, these
results demonstrate that P. aeruginosa produces one or more
enzymes with PCA reduction activity.
We attempted to purify anNADH:PCAorNADPH:PCAoxi-
doreductase from P. aeruginosa cell lysate using anion-ex-
change, cation-exchange, and hydrophobic interaction chro-
matography. Unfortunately, our efforts were hampered by the
abiotic reaction between NAD(P)H and PCA, which is greatly
accelerated at higher salt concentrations involved in protein
chromatography. We struggled to locate chromatographic
peaks of activity from the high background. To learn more
about the types of proteins that might catalyze phenazine
reduction, we opted to characterize the phenazine reduction
activity in terms of cellular localization and sensitivity toward
chemical inhibitors.
Multiple Enzymes Can Catalyze Phenazine Reduction—We
wonderedwhether the electron transport chain catalyzes phen-
azine reduction, because pyocyanin is reported to stimulate res-
piration (5, 6) and phenazines inducemorphological changes in
colony biofilms that are consistent with increased respiration
(8). To test whether PCA reduction activity derivesmostly from
the membrane-bound electron transport chain, we separated
membrane-associated components from the lysate by ultracen-
trifugation (note that some soluble components, such as ribo-
somes, -oxidationmachinery, and 2-oxoacid dehydrogenases,
can also be pelleted by ultracentrifugation). We saved the
supernatant containing soluble proteins and resuspended the
membrane pellet with a gentle non-ionic detergent. We then
tested the three fractions (crude lysate, soluble proteins, and
membrane-associated proteins) for PCA reduction in terms of
absolute rate and specific activity.
Both the soluble andmembrane fractions contained approx-
imately equal activity, but specific activity (activity normalized
by protein concentration) was 2-fold greater in the soluble frac-
tion relative to the membrane fraction (Fig. 3). In the mem-
brane samples, the calculated final concentration of reduced
PCA (300–350M)was greater than the amount initially added
to the spectrophotometric assay (250 M) (Fig. 3). This artifact
may be due to redox-active cytochromes absorbing at the same
wavelength as PCA or residual endogenous phenazines associ-
ated with the membrane, and so our data might overestimate
the rate of PCA reduction in membrane fractions. Citrate and
isocitrate stimulated PCA reduction primarily in the soluble
fraction (Fig. 3). Notably, for the 2-oxoacids pyruvate and -
ketoglutarate, ultracentrifugation significantly lowered PCA
reduction activity, but we did not recover this activity in the
membrane fraction (Fig. 3). Because many enzymes in central
metabolism use NAD(P)H as an electron carrier, from these
data we infer that the cell lysate contains at least twoNAD(P)H:
PCA oxidoreductases that are distributed between the soluble
andmembrane fractions, with more activity residing in the sol-
uble fraction. This implies that the electron transport chain
does not exclusively reduce PCA in vitro. Additional enzymes
might also use citrate, isocitrate, pyruvate, or-ketoglutarate as
electron donors.
We further probed the lysate using three inhibitors as fol-
lows: (a) cyanide to inhibit metalloproteins and heme-contain-
ing proteins (35); (b) diphenyleneiodonium to inhibit flavopro-
teins and some heme-containing proteins (36); and (c) arsenite
to inhibit thiol-dependent proteins (37). Cyanide only slightly
inhibited activity, whereas diphenyleneiodonium greatly inhib-
ited activity with all of the electron donors tested (Fig. 4).
Arsenite specifically inhibited activity only for pyruvate and
-ketoglutarate (Fig. 4). Together, the differential localization
and inhibitor activities suggest that P. aeruginosa lysate con-
tains multiple enzymes that catalyze PCA reduction. The
strong inhibition by diphenyleneiodonium (Fig. 4) further sug-
gests that flavoproteins and/or heme-containing proteins may
catalyze PCA reduction.
Pyruvate and -Ketoglutarate Dehydrogenase Catalyze
Phenazine Reduction—Our experiments with cell lysate sug-
gested a role for the pyruvate and -ketoglutarate dehydroge-
nases in PCA reduction. Not only did pyruvate and -keto-
glutarate stimulate PCA reduction (Fig. 3), but the pattern of
localization and inhibition was consistent with the conserved
FIGURE 2. Catalytic reduction of PCA by P. aeruginosa cell-free lysate.
Each panel illustrates a time course of PCA reduction using the indicated
electron donor. The line and shaded region represent themean and standard
deviation, respectively, from three independent assays using lysate prepared
from independent cultures. The final concentrations in the assay were 1 mM
for NADH and NADPH, 5 mM for racemic DL-isocitrate (to give 2.5 mM D-isoci-
trate), and 2.5 mM for all other donors.
Phenazine Reduction in P. aeruginosa
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mechanism of the 2-oxoacid dehydrogenase complexes (38,
39). In the 2-oxoacid dehydrogenase complexes, the E1 subunit,
the substrate dehydrogenase, conjugates the substrate to pyro-
phosphate (TPP) with concomitant decarboxylation. The TPP
cofactor is regenerated by transferring the substrate onto a lipo-
amide cofactor covalently attached to the E2 subunit. The E2
subunit, dihydrolipoyl transacetylase, then regenerates lipoam-
ide by transferring the substrate to CoA, producing dihydroli-
poamide. The dihydrolipoamide is finally re-oxidized by the E3
subunit, dihydrolipoamide dehydrogenase (DLDH), by trans-
ferring electrons to NAD through a flavin in the form of a
tightly bound FAD.
We recognized that the megadalton-sized 2-oxoacid dehy-
drogenases can be pelleted by ultracentrifugation, which would
explain why 2-oxoacid-dependent activity was depleted by
ultracentrifugation (Fig. 3), and the cofactor requirement could
explain why activity was not recovered in the membrane frac-
tion (Fig. 3) because cofactors would remain in the soluble frac-
tion. The obligate reduction and oxidation of the lipoamide
thiols is consistent with inhibition by arsenite (Fig. 4). More-
over, oxidation of the lipoamide cofactor requires a flavopro-
tein subunit, consistent with inhibition by diphenyleneiodo-
nium (Fig. 4). We therefore asked whether the pyruvate and
-ketoglutarate dehydrogenase complexes were sufficient to
catalyze phenazine reduction and, if so, what electron transfer
pathway was employed.
To answer this question, we isolated the native pyruvate and
-ketoglutarate dehydrogenase complexes from P. aeruginosa
(detailed under “Experimental Procedures”). As judged byCoo-
massie staining of an SDS-polyacrylamide gel, the complexes
FIGURE 3. Fractionation of PCA reductase activity in cell-free lysate.Cell-free lysatewas fractionated into soluble- andmembrane-associated components
byultracentrifugation. The fractionswere assayed for their ability to catalyzePCA reduction. Left,eachpanel illustrates a timecourseof PCA reductionusing the
indicated electron donor. The line and shaded region represent the mean and standard deviation, respectively, from four independent assays using lysate
prepared from independent cultures. The solid portionof each line indicates the linear regionused forquantification.Right, specific activity for each fractionwas
determined by normalizing the rate of PCA reduction, illustrated with a solid line in the left panels, by the protein concentration of each fraction. Error bars
represent the standard deviation from four independent biological replicates.
FIGURE 4. Inhibition of PCA reduction activity in cell-free lysate. Unfractionated cell-free lysate was assayed for its ability to catalyze PCA reduction in the
presence of the indicated inhibitors. Left, each panel illustrates a time course of PCA reduction using the indicated electron donor. The line and shaded region
represent themean and standard deviation, respectively, from four independent assays using lysate prepared from independent cultures. The solid portion of
each line indicates the linear region used for quantification. Right, specific activity for each fraction was determined by normalizing the rate of PCA reduction,
illustrated with a solid line in the left panels, by the protein concentration of each sample. Error bars represent the standard deviation of four independent
biological replicates.
Phenazine Reduction in P. aeruginosa
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were90% pure (Fig. 5A). The -ketoglutarate dehydrogenase
preparation contained no detectable pyruvate dehydrogenase
(0.1%), whereas the pyruvate dehydrogenase preparation
contained a small amount of contaminating-ketoglutarate de-
hydrogenase (4%) as measured by NAD reduction activity.
The purified complexes catalyzed PCA (Fig. 5B) and pyocy-
anin (Fig. 5C) reduction using their respective electron donors.
We normalized the reaction rate to the protein flavin content
(as a measure of dihydrolipoamide dehydrogenase) rather than
defining the number of active sites in a large, potentially heter-
ogeneous complex with multiple reaction steps. A Michaelis-
Menten kinetic model fit to the initial rate of PCA reduction
(Fig. 5B) yielded a Km of 260 M and Vmax of 32 min1 for
pyruvate dehydrogenase and a Km of 190 M and Vmax of 40
min1 for -ketoglutarate dehydrogenase. The initial rates of
pyocyanin reduction did not depend on the pyocyanin concen-
tration (Fig. 5C), implying a Km of less than 25 M for pyocya-
nin. Interestingly, although the pyruvate and -ketoglutarate
dehydrogenase complexes reduced PCA at similar rates (Fig.
5B), pyruvate dehydrogenase reduced pyocyanin considerably
slower than did -ketoglutarate dehydrogenase (Fig. 5C).
Cyanide, diphenyleneiodonium, and arsenite inhibited PCA
and pyocyanin reduction by the purified complexes (Fig. 5, B
and C). The relative inhibition of the purified complexes mir-
rored that of whole cell lysate (Fig. 4), with cyanide partially
inhibiting PCA reduction, and both arsenite and diphenylenei-
odoniummore fully inhibiting PCA reduction (Fig. 5, B andC),
indicating that the 2-oxoacid dehydrogenase complexes can
account for the activity in lysate.
In control experiments, PCA and pyocyanin reduction by the
purified complexes required all known substrates and cofac-
tors. We detected no activity when the electron donor (pyru-
vate or -ketoglutarate), coenzyme A, or magnesium were
omitted from the reactionmixture.We observed residual activ-
ity (1%) in the absence of TPP, possibly due to co-purification
of trace amounts of this cofactor with the protein. Although we
cannot rule out catalysis by a contaminant in our enzyme prep-
aration, the inhibition by arsenite and diphenyleneiodonium
and the requirement for the known cofactors of pyruvate and
-ketoglutarate dehydrogenase indicate that the 2-oxoacid de-
hydrogenase complexes directly catalyze PCA and pyocyanin
reduction.
Dihydrolipoamide Dehydrogenase Catalyzes Phenazine Reduc-
tion—We next asked which 2-oxoacid dehydrogenase subunit
catalyzes phenazine reduction. In the absence of CoA, the E1
subunit catalyzes ferricyanide and dichloroindophenol reduc-
tion (40, 41). However, we observed no PCA or pyocyanin
reduction in the absence of CoA, suggesting these phenazines
are not reduced by the E1 subunit. As the E3 subunit has long
been recognized to reduce methylene blue (41), a molecule
structurally similar to phenazines (Fig. 1), and the porcine and
malarial E3 subunits have been shown to catalyze pyocyanin
reduction (28), we hypothesized that the P. aeruginosa E3 sub-
unit (DLDH) catalyzes phenazine reduction.
Strain PA14 encodes the following three DLDH homologs in
its genome: LpdG (PA14_43970); Lpd3 (PA14_63850); and
LpdV (PA14_35490) (42, 43). We purified His-tagged versions
of each protein. All three enzymes catalyzed PCA and pyocya-
nin reduction using bothNADH and dihydrolipoamide as elec-
tron donors (Fig. 6A). Phenazine reduction by both dihydroli-
poamide and NADH, the substrate and product of the
physiological reaction, respectively, is consistent with the FAD
cofactor acting as a bidirectional electron-transfer intermedi-
ate, suggesting that phenazines interact with the flavin during
the catalytic cycle of DLDH. In the context of the full 2-oxoacid
dehydrogenase complexes, we propose that phenazines can
substitute for NAD as the final electron acceptor of pyruvate
and -ketoglutarate oxidation. This contrasts with our previ-
ous assumption that phenazines serve as an oxidant for NADH
(20).
Before probing the interaction between phenazines and
DLDH, we determined the enzymatically relevant DLDH ho-
molog for the 2-oxoacid dehydrogenase complexes. Although
the pyruvate dehydrogenase complex of P. aeruginosa has been
purified before (44), the precise identity of its constituent
DLDHwas not determined, and the operon encoding pyruvate
dehydrogenase does not contain an associated DLDH. In con-
trast, the operon encoding -ketoglutarate dehydrogenase
encodes all three subunits (E1, E2, and E3 (LpdG)). Phenotypic
evidence in Pseudomonas putida suggests the E3 component of
pyruvate dehydrogenase is LpdG, but Lpd3 may substitute in
the absence of LpdG (45). To address this ambiguity, we excised
the band corresponding toDLDH from an SDS-polyacrylamide
FIGURE 5. Preparation and characterization of the pyruvate and -keto-
glutarate dehydrogenase complexes. A, Coomassie Blue-stained SDS-
polyacrylamide gel of the purified pyruvate dehydrogenase (PDH) and -ke-
toglutarate (KGDH) complexes. The three prominent bands represent the
three subunits of the complex as labeled. PDH, E1 (pyruvate dehydrogenase;
AceE, E2 (dihydrolipoamide acetyltransferase, AceF); E3 (dihydrolipoamide
dehydrogenase, LpdG); KGDH, E1 (-ketoglutarate dehydrogenase, SucA),
E2 (dihydrolipoamide succinyltransferase, SucB); E3 (dihydrolipoamide dehy-
drogenase, LpdG). B and C, PCA (B) and pyocyanin (C) reduction by the puri-
fied complexes in the absence or presence of the indicated inhibitors. The
dashed line represents the fitted Michaelis-Menten binding curve.
Phenazine Reduction in P. aeruginosa
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gel (Fig. 5A), performed an in-gel trypsin digest, and analyzed
the resulting peptide fragments using LC-MS/MS. As expected
from its operon structure, the DLDH peptides from -keto-
glutarate dehydrogenasemapped to LpdG (Table 1). The DLDH
peptides from pyruvate dehydrogenase also mapped to LpdG
(Table 1), with only 0.03%of peptide intensitymapping to Lpd3,
indicating that LpdG is the primary DLDH of the P. aeruginosa
PA14 pyruvate dehydrogenase.We detected no peptides corre-
sponding to LpdV in either complex (Table 1). We also con-
firmed the identity of dihydrolipoamide acetyltransferase in
our pyruvate dehydrogenase preparation (Table 1), as this band
migrated slower than expected for its predicted size of 56.7 kDa
(Fig. 5A).
Having established LpdG as the enzymatically relevant
DLDH for both pyruvate and -ketoglutarate dehydrogenase,
we quantified the interaction between LpdG and phenazines in
more detail.Wemeasured the binding affinity,Kd, by exploiting
the intrinsic fluorescence of the flavinmoiety in the FAD cofac-
tor of LpdG.We anticipated that binding of an aromatic group
near the flavin would quench fluorescence, thereby providing a
direct measure of substrate binding. This prediction was borne
out experimentally. High concentrations of PCA were suffi-
cient to quench fluorescence (Fig. 6B), consistent with binding
near the flavin. The extrapolated Kd is 84 mM with a Hill coef-
ficient of 1.95 (Fig. 6B). In support of a cooperative model of
binding, a non-cooperative model (Hill coefficient  1)
required a nonsensical large negative minimum fluorescence
and an unrealistically largeKd (1000mM). In contrast to PCA,
the positively charged methylene blue quenched fluorescence
with a Kd of 170 M and a Hill coefficient of 1.27 (Fig. 6B). We
were unable to apply this method to pyocyanin, which is water-
soluble at pH 7.5 only to 1 mM or to phenazine-1-hydroxide
and phenazine-1-carboxamide, which are even less soluble. Hill
coefficients of less than two are consistent with the dimeric
structure of DLDH. Cooperative substrate binding in DLDH
has been observed for NADH (46) and may originate from the
architecture of the active site, which contains residues from
both chains of the DLDH homodimer (47, 48), potentially
allowing for substrate binding to induce long range conforma-
tional changes within the protein.
Structural Insights into the Interaction between LpdG and
Phenazines—Although the affinity of the P. aeruginosa LpdG
for PCA appears to be low, we were encouraged by the compar-
atively high affinity for methylene blue, and so we attempted to
solve the X-ray crystal structure of LpdG bound to a phenazine
or methylene blue. LpdG crystallized in multiple screens using
polyethylene glycol as a precipitant, similar to previously dis-
covered conditions for DLDH.During optimization, we discov-
ered a new crystal form in which over 90% of crystals diffracted
to 1.8 Å or better in the space group P21. One crystal diffracted
to 1.43 Å (Fig. 7A) with a signal-to-noise cutoff of 2.0, which we
refined to 1.35 Å using paired refinement (49), representing the
highest published resolution of any DLDH to date.
Apart from minor rotamer corrections and the orientations
of some surface residues, our model of LpdG at 1.35 Å is essen-
tially identical to the previously reported structure at 2.8 Å (the
rootmean square deviation is less than 0.4 over 470-carbons),
and so we defer to the original publication byMattevi et al. (47)
for a full structural description. A noteworthy feature unique to
our model is the association of LpdG with the cryoprotectant
DMSO.We observed twomolecules of DMSO inside the active
FIGURE 6. Phenazine reduction and binding by DLDH homologs of
P. aeruginosa. A, time courses of PCA and pyocyanin reduction by DLDH
using both NADH and dihydrolipoamide (lipoSH) as electron donors. Solid
lines indicate the presence of 2M enzyme.Dashed lines indicate the absence
of enzyme. Shaded regions indicate the standard deviation of three technical
replicates. B, affinity of LpdG for PCA and methylene blue as measured by
fluorescence quenching. The dashed line indicates the binding curve fitted to
the data. The data points are normalized to the maximum and minimum
values of the fitted curve.
TABLE 1
LC-MS/MS confirmation of constituent proteins in the purified
2-oxoacid dehydrogenase complexes
ND, not detected; iBAQ, intensity-base absolute quantification.
Banda
Unique
peptidesb Intensityc iBAQd
Pyruvate dehydrogenase E3
LpdG 45 85.1% 83.9%
Lpd3 9 0.030% 0.035%
LpdV 0 ND ND
-Ketoglutarate dehydrogenase E2
LpdG 39 85.9% 82.0%
Lpd3 0 ND ND
LpdV 0 ND ND
Pyruvate dehydrogenase E2
AceE 46 80.4% 81.6%
a Band labels correspond to the gel shown in Fig. 5A. Each sub-row shows infor-
mation about proteins of interest for a given gel band.
bNumber of unique peptides observed for the indicated protein within the indi-
cated band is shown.
c Percent peptide abundance was based on the raw signal intensity of identified
peptides.
d Percent peptide abundance using the iBAQ method (26) is shown.
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site where dihydrolipoamide is postulated to bind (Fig. 7B).
This orientation appears to be stabilized by a sulfur- interac-
tion between the central sulfur atom of DMSO and a histidine
side chain. This configuration might mimic the binding of the
dihydrolipoamide sulfhydryl groups in the active site of LpdG.
Crystals soaked for 1 h with 10 mM NADH or NAD yielded
electron densities corresponding to the soaked substrate (Fig. 7,
C and D). As observed previously with human DLDH (50), we
could not resolve electron density for the nicotinamide group of
NAD (Fig. 7D), suggesting the oxidized cofactor is disordered
or present in multiple conformations. Statistics for the apo-,
NAD-, and NADH-bound structures are shown in Table 2.
Our initial screens yielded no crystals when 2 mMmethylene
blue or 250mMPCAwas included in the protein solution, so for
these substrates we focused on soaking into preformed crystals.
Unfortunately, we observed no electron density assignable to a
phenazine after soaking for up to 1weekwith 10mMpyocyanin,
10mMphenazine-1-carboxamide, 10mMphenazine-1-hydrox-
ide, 5 mM methylene blue, or up to 175 mM PCA. We were
similarly unsuccessful when the soaks included up to 100 mM
dithionite or 100mMdihydrolipoamide to generate the reduced
forms of LpdG and substrate. Above 200mMPCA, we observed
an electron density characteristic of a -stacking interaction
between PCA and aromatic residues on the surface of the
protein (Fig. 7E), but this interaction is unlikely to be phys-
iologically relevant because of the high PCA concentration it
requires.
The crystal structure reveals a carefully structured nicotin-
amide-binding site that sterically excludes larger molecules
such as phenazines (Fig. 7, C and D), likely explaining why we
were unable to obtain crystals bound to a phenazine. In partic-
ular, an isoleucine side chain (Ile-192) restricts access to the
flavin. The smaller nicotinamide moiety of NADH forms a
-stack with the flavin that is further stabilized by hydrogen
bonding of the amide groupwithGlu-195 and the peptide back-
bone (Fig. 7C). Assuming no other conformational changes,
extending nicotinamide to contain three rings yields a steric
clash with Ile-192 and disrupts the stabilizing hydrogen bonds
(Fig. 7F). Based on this structural interpretation, we hypothe-
sized that mutating Ile-192 to a smaller residue might increase
accessibility of the flavin to phenazines, thereby accelerating
DLDH-catalyzed phenazine reduction.Wewere also interested
FIGURE 7. Structural analysis of LpdG.Where visible, the embedded FAD cofactor is shown in red. Protein side chain carbons are shown in purple.A, overview
of the LpdG dimer. The two polypeptides of the biological assembly are shown in shades of blue. B, close-up of DMSO bound in the lipoamide binding pocket.
The orange mesh represents the anomalous difference map contoured at 4, which highlights sulfur atoms and the phosphorus atoms in FAD. The DMSO
carbon atoms are shown in green. C and D, close-up of NADH (C) and NAD (D) bound to LpdG. Electron density was not visible for the oxidized nicotinamide
group in NAD, and so this group has not beenmodeled. The bluemesh represents the 2mFoDFcmap of electron density for FAD and NAD(H) contoured at
1.5. The NAD(H) carbon atoms are shown in yellow. The dashed line illustrates a hydrogen bond interaction. E, example of-stacking interactions at a surface
residue in a crystal soaked with 225 mM PCA. The green mesh represents positive density in the 2mFo DFc difference map contoured at 3. F, hypothetical
illustration of a phenazine (orange) substituting for NADH, demonstrating a steric clashwith Ile-192. The phenazinewas placedmanually in Coot and does not
represent a real dataset.
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in Val-191, which sits above the flavin-nicotinamide-stack. In
other homologs, and the closely related glutathione reductase,
this residue is a tyrosine that may regulate NADH binding or
reactivity through additional -stacking and compression (51).
We therefore generated two site-directed mutants of LpdG,
I192G and V191Y. Contrary to our expectations, the I192G
mutant catalyzed PCA reduction more slowly than wild type
LpdGand also appeared to be substrate-inhibited (Fig. 8A). The
V191Y mutation also lowered enzyme activity and conferred
substrate inhibition (Fig. 8A). The mutations did not affect the
PCA concentration required to quench LpdG fluorescence
(Fig. 8B), demonstrating that the binding affinity remained
unchanged in themutants. Together, these results indicate that
residues Val-191 and Ile-192 do not sterically hinder PCA from
binding to LpdG.
Discussion
The search for phenazine reductases was motivated by our
interest in phenazine-mediated anaerobic survival and energy
generation (19, 20). Our work here suggests that, rather than
possessing an enzyme with specific phenazine reductase activ-
ity, P. aeruginosamakes a variety of redox-active enzymes that
adventitiously reduce phenazines under anoxic conditions. By
subsequently reactingwithmolecular oxygen or ferric iron (16),
phenazines would enable the oxidation of metabolites in a
manner independent of the electron transport chain. The elec-
tron donor for this process could be the metabolite itself, for
example pyruvate or -ketoglutarate, without involvement of
another cofactor such asNAD(P)H.Through extracellular elec-
tron transport in a microbial community (8), this mechanism
would allow multiple metabolic pathways, such as glycolysis or
pyruvate oxidation (20), to support energy generation for cells
locally starved of an electron acceptor (i.e. oxygen or nitrate).
We identified the pyruvate and -ketoglutarate dehydroge-
nase complexes as phenazine reductases (Fig. 5) based on activ-
ity assays in whole cell lysate (Fig. 2) and the pattern of fraction-
ation and inhibition (Figs. 3 and 4). We focused on this specific
subset of enzymes becausewe previously found that phenazines
enable ATP synthesis through the conversion of glucose to ace-
tate by serving as an electron acceptor (20). Notably, this path-
way requires pyruvate dehydrogenase. In our prior work, we
hypothesized that phenazines stimulate pyruvate dehydroge-
nase by convertingNADH toNAD (20), a limiting substrate in
the absence of a terminal electron acceptor. Our results here
suggest that phenazines may instead directly substitute for
NAD in the pyruvate dehydrogenase complex during anaero-
bic survival. Under NAD-limiting conditions (e.g. hypoxia),
phenazines could therefore increase metabolic flux through
pyruvate dehydrogenase. The phenazine reduction activity of
pyruvate dehydrogenase is admittedly low (Vmax  32 min1
for PCA) (Fig. 5), but it may be compatible with the low meta-
bolic activities observed in anoxic planktonicmodels of survival
(20, 52).
Importantly, the affinity we measured of pyruvate dehydro-
genase for phenazines (Km of 260 M for PCA and25 M for
pyocyanin) is within the physiological range produced by
P. aeruginosa, which can reach up to 200 M within infection
contexts (53). We observed a large mismatch between the
ligand binding affinity of the catalytic subunit LpdG (i.e. Kd, Fig.
TABLE 2
Crystallography data collection and refinement statistics
Values in parentheses are for the highest resolution shell.
LpdG LpdG with NAD LpdG with NADH
Data collection
Space group P21 P21 P21
Unit cell
a, b, c (Å) 65.32, 116.28, 136.59 65.61, 116.69, 136.86 65.51, 117.83, 139.73
, ,  (°) 90, 94.735, 90 90, 94.871, 90 90, 94.302, 90
Resolution range (Å) 37.52–1.35 (1.398–1.35) 38.90–1.45 (1.502–1.45) 34.93–1.79 (1.854–1.79)
Unique reflections 443,431 (44,051) 361,916 (36,058) 198,611 (19,792)
Rpim (%) 1.72 (48.7) 1.91 (48.0) 2.39 (39.11)
I/(I)	 19.81 (1.40) 21.06 (1.53) 18.36 (2.65)
Completeness (%) 99.88 (99.46) 99.98 (99.98) 99.98 (99.98)
Multiplicity 13.6 (13.4) 13.6 (13.0) 13.5 (13.8)
Wilson B-factor (Å2) 17.93 19.42 28.19
Refinement
Resolution range (Å) 37.52–1.35 38.9–1.45 34.93–1.79
Rwork/Rfreea 0.1325/0.1565 0.1521/0.1736 0.1667/0.1785
No. of non-H atoms
Protein 13,905 13,863 13,661
Water 2,383 2105 1228
DMSO 156 128 80
Root mean square deviation
Bond lengths (Å) 0.012 0.004 0.004
Bond angles (°) 1.21 0.768 0.745
Average B-factors (Å2)
Protein 24.37 24.88 40.01
Water 40.72 37.43 43.78
Ligandb 27.31 28.39 43.58
Ramachandran (%)
Favored 97.51 97.14 96.55
Allowed 2.49 2.86 3.45
Outliers 0 0 0
PDB accession code 5U8U 5U8V 5U8W
a A total of 1.18% of reflections were excluded from refinement for cross-validation.
b Data includes DMSO.
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6B) and the concentration required to saturate the reaction rate
in the full complex (i.e. Km, Fig. 5, B and C). LpdG is natively
associated with the larger complex, and so the rate saturation
of the full complex likely represents the more physiologically
meaningful result. The large disparity in magnitude suggests
that LpdG is not rate-limiting within the full complex and/or
that binding to the complex induces substantial changes in the
affinity of LpdG for its substrates. Given the high Kd value for
PCA, we would not expect PCA to outcompete NAD unless
the concentrations of available NAD were very low, but we
note that this is precisely the condition where phenazinesman-
ifest a physiological benefit for P. aeruginosa (7, 8, 19, 20).
The phenazine reductase activity of pyruvate dehydrogenase
is particularly intriguing in the context of biofilm maintenance
and development. The inner core of established biofilms is
anoxic (8, 54) and enters a metabolically repressed state with
decreased respiration and increased substrate-level phosphor-
ylation (54). In the absence of oxygen, P. aeruginosa can survive
by mixed-acid fermentation of pyruvate to acetate and lactate
(52), a process that is enhanced by phenazine redox cycling (20).
This suggests amodel where cells at the anoxic core of a biofilm
may use pyruvate dehydrogenase, with phenazines as an elec-
tron acceptor and coupled to substrate-level phosphorylation,
to maintain a basal level of energy generation; reduced
phenazines could then be re-oxidized at the oxygen-rich sur-
face of the biofilm. In addition to maintaining energy genera-
tion in anoxic regions of biofilms (8), phenazines can also
stimulate biofilm formation through iron acquisition (55),
extracellular DNA release (56), and other unknown mecha-
nisms (55–57). In the context of ourwork here, it is striking that
early biofilm development in P. aeruginosa requires pyruvate
fermentation and redox homeostasis (58). It is tempting to
speculate that the biofilm-promoting behavior of phenazines
and pyruvate fermentation could be mechanistically linked
through the activity of pyruvate dehydrogenase.
We do not mean to suggest that pyruvate and -keto-
glutarate dehydrogenase are the only relevant phenazine reduc-
tases in vivo. Indeed, NADH andNADPH aremore effective than
the 2-oxoacids at stimulating PCA reduction in cell lysate (Figs.
2–4). The 2-oxoacid:PCA oxidoreductase activity in lysate
could be explained by the 2-oxoacid dehydrogenases reducing
NAD to NADH, enabling the activity of an NADH:PCA oxi-
doreductase. Similarly, the stimulation by citrate and isocitrate
(Figs. 2–4) could result from the downstream production of
NAD(P)H. Therefore, our results with cell lysate are best inter-
preted as an upper limit to the overall PCA reductase activity of
pyruvate and-ketoglutarate dehydrogenase.With that caveat,
we also found that diphenyleneiodonium is a strong inhibitor of
PCA reduction (Fig. 4). Notably, diphenyleneiodonium is a
known flavoprotein inhibitor that conjugates to reduced flavins
via a radical-mediated mechanism, although it can also inhibit
some heme proteins (36). This is consistent with our finding
that the flavoenzyme LpdG, the E3 subunit of the 2-oxoacid
dehydrogenases studied here (Table 1), directly catalyzes PCA
and pyocyanin reduction (Fig. 6). Together, these findings sug-
gest that flavoproteins, and possibly some heme-containing
proteins, account for themajority of phenazine reductase activ-
ity in P. aeruginosa.
Ultimately, pyruvate and -ketoglutarate dehydrogenase
serve to demonstrate that many electron donors, through the
activity of their catabolic enzymes, could support phenazine
reduction. By accepting electrons from flavoproteins, a ubiqui-
tous class of proteins important for metabolism, phenazines
could potentially alter metabolic flux through a number of
pathways. A quantitative prediction of this activity de novo is
presently impossible. Even for the adventitious reduction of
oxygen, the most studied side-reaction of flavoproteins, the
parameters that govern reaction rates (which differ by at least 6
orders of magnitude) are still unclear (59). Mirroring this
uncertainty, our prediction that sterics are the rate-limiting fac-
tor for phenazine reduction by LpdG did not hold up to site-
directed mutagenesis (Fig. 8), suggesting that even for the
restricted active site of LpdG, the enzyme-specific particulars of
electronic structure and transition state are important. Beyond
enzyme kinetics, phenazine reduction varies by growth phase
(7), and sowe expect the overall effects of phenazines onmetab-
olism to be heavily context-dependent. For example, within a
ok;4heterogeneous and stratified biofilm community, different
enzymes likely catalyze phenazine reduction under (hyp)oxic
and anoxic conditions. The results of this study, indicating that
oxidized PCA and pyocyanin can substitute forNAD, allow us
to postulate that under strictly anaerobic conditions, where
NAD may be limited (7, 20), substitution of phenazines for
FIGURE 8. Site-directed mutagenesis of LpdG. A, PCA reduction by site-
directedmutants of LpdG. The initial rate of reductionwas normalized by the
concentration of protein (2 M) and subtracted by the abiotic rate of reduc-
tion asmeasuredwithout protein. Error bars represent the standarddeviation
of four technical replicates.B, affinity of site-directedmutants of LpdG for PCA
asmeasuredby fluorescencequenching. The fluorescence values arenormal-
ized to the maximum fluorescence for each mutant.
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NAD in enzymes like LpdG would facilitate redox homeosta-
sis. This is in a manner distinct from what we have previously
assumed (the coupling ofNADHoxidation to phenazine reduc-
tion) but results in the same net effect, maintenance of a higher
NAD/NADH ratio. Such substitution would allow for flux
through pathways thatwould otherwise not proceed, including,
but not limited to, energy-generation pathways such as pyru-
vate oxidation (20). A comprehensive understanding of phena-
zine metabolism in vivo will require a synthesis of biochemical
and genetic approaches, yet this study helps focus our attention
on potentially important enzymatic catalysts and pathways.
Experimental Procedures
Materials—The reagents used for growth media and protein
purification were from Sigma or Acros Organics and were of
ACS grade or better. Pyocyanin was from Cayman Chemicals.
Phenazine-1-carboxylic acid and phenazine-1-carboxamide
were from Princeton Biosciences. Phenazine-1-hydroxide was
from TCI America. NAD, NADH, thiamine pyrophosphate,
coenzyme A, MgCl2, lipoamide, potassium cyanide, diphenyle-
neiodonium chloride, and sodium (meta)arsenite were from
Sigma. Dihydrolipoamide was synthesized from lipoamide by
reduction with sodium borohydride (60) and stored desiccated
at 20 °C. For crystallography, PEG-3350 (50% solution) was
from Hampton Research, and DMSO, HEPES, KOH, and KCl
were from Sigma. Nickel-Sepharose and Sephacryl S-400 were
from GE Healthcare. CHT hydroxyapatite was from Bio-Rad.
Thrombin was from EMD Millipore. Other chemicals were
from Sigma unless stated otherwise. All phosphate buffers were
prepared with KH2PO4 and adjusted to the appropriate pH
with KOH at room temperature. Anaerobic buffers were pre-
pared by autoclaving and transferring the still-warm solution
into an anaerobic chamber; other anaerobic solutionswere pre-
pared by dissolving solid compounds with anaerobic buffers
within the anaerobic chamber.
GrowthConditions—For routine culturing,P. aeruginosa and
Escherichia coli were grown in lysogeny broth containing 10
g/liter tryptone, 5 g/liter yeast extract, and 10 g/literNaCl. Solid
agar plates contained 15 g/liter agar. The succinate minimal
medium for P. aeruginosa contained 14.15 mM KH2PO4, 35.85
mM K2HPO4, 42.8 mM NaCl, 9.3 mM NH4Cl, 40 mM disodium
succinate, 1 mMMgSO4, 7.5 M FeCl24H2O, 0.5 M ZnCl2, 0.5
M MnCl24H2O, 0.1 M H3BO3, 0.8 M CoCl26H2O, 0.01 M
CuCl22H2O, 0.1 M NiCl26H2O, and 0.15 M Na2MoO4. The
minimalmediumwas sterilized by autoclaving; to avoid precip-
itation, themetalswere prepared as a separate solution (1000
)
and added immediately prior to inoculation. All liquid cultures
were incubated in a New Brunswick Innova 44R incubator at
37 °C shaking at 250 rpm (2.54-cm stroke length).
PCA Reduction by Cell Lysate—Wild type P. aeruginosa
PA14 was incubated in 250-ml Erlenmeyer flasks containing 50
ml of succinate minimal medium and grown to an A500 of 2.4–
2.8 (11 h from a starting A500 of 0.01). The cells were har-
vested by centrifugation for 15 min at 6800 
 g, washed twice
with 1ml of 50mMKH2PO4, pH 7.5, and resuspended to a final
volume of 1 ml with 50 mM KH2PO4, pH 7.5, and 1 mM phen-
ylmethylsulfonyl fluoride (PMSF). The cells were lysed by son-
ication on ice using a Thermo Fisher Scientific Sonic Dismem-
brator 550 set to power level 3 with a pulse setting of 1 s on, 4 s
off for 3 min total sonication time. Large debris and unlysed
cells were removed by centrifugation for 15 min at 8000 
 g.
Where applicable, membrane-associated proteins were sepa-
rated by ultracentrifugation using a BeckmanOptima ultracen-
trifuge with a TLA-100.3 fixed-angle rotor. The lysate was cen-
trifuged for 1 h at 70,000 rpm (208,000 
 g average), and the
supernatant was saved. The pellet was resuspended by gently
pipetting an equivalent volume of 50mMKH2PO4, pH 7.5, with
1% n-dodecyl -D-maltoside and 1 mM PMSF. Undissolved
material was removed by centrifugation for 15min at 8000
 g.
Protein concentration was measured using the bicinchoninic
acid assay (Pierce) (61) calibrated with BSA standards (Pierce).
Boiled lysate was prepared by placing an aliquot into a boiling
water bath for 5 min; the precipitated material was removed by
centrifugation at 17,000
 g for 5 min.
PCA reduction assays were performed inside an anaerobic
glove box (Coy) with an atmosphere of 3–4% H2 and 97–96%
N2. Reactions were performed at 28 °C in a 96-well plate with
each well containing 50 l of lysate, 50 l of electron donor
(dissolved in 50 mM KH2PO4, pH 7.5), and 50 l of buffer (50
mMKH2PO4, pH 7.5) or boiled lysate.Where applicable, inhib-
itors were added using 2 l of a 100
 stock solution (KCN and
NaAsO2 were dissolved in water; diphenyleneiodonium chlo-
ride was dissolved in DMSO). The reaction was initiated by
adding 50l of PCA (1mM stock in 50mMKH2PO4, pH7.5; 250
M final concentration). The reaction was monitored by mea-
suring absorbance at 440 nm using a BioTek Synergy 4 plate
reader housed within the anaerobic glove box. The reaction
progress was normalized against four averaged control wells
containing 250MPCA and 10mM sodiumdithionite as amea-
sure of 100% PCA reduction.
Pyruvate and -Ketoglutarate Dehydrogenase Purifica-
tion—The pyruvate and -ketoglutarate dehydrogenase com-
plexes were prepared natively from P. aeruginosa PA14
phz1/2 (34). This phenazine-null strain was used to minimize
the generation of reactive oxygen species during the initial
stages of purification. Cells were grown in 1 liter of the succi-
nate minimal medium (with 80 mM disodium succinate to
achieve higher cell density) in a 2.8-liter baffled Fernbach flask
to an A500 of 4–6. In a typical preparation, 6 liters of cells were
harvested by centrifugation for 15 min at 8000 
 g. The cells
were resuspended in 200 ml of 50 mM KH2PO4, adjusted to pH
7.5 with KOH, with 1 mM EDTA, and a cOmplete ULTRA pro-
tease inhibitor tablet (Roche Applied Science). The cells were
lysed using 3 or 4 passes through an Avestin Emulsiflex-C3
operating at 20,000 p.s.i. The lysate was centrifuged for 30 min
at 30,000
 g, and the pellet was discarded. In subsequent steps,
the activity of the complexes was followed using a reaction mix
containing 50 mM KH2PO4, pH 7.5, 1 mM MgCl2, 100 M TPP,
100 M CoA, 500 M NAD, and 2.5 mM pyruvate or -keto-
glutarate. Activitywas indicated by an absorbance increase over
time at 340 nm after adding 1–5 l of lysate or protein to 199–
195 l of the reaction mix.
After adjusting the lysate dropwise with 5% acetic acid to pH
6.0 on ice, 0.17 volumes of 2% protamine sulfate were added,
and the mixture was gently stirred on ice for 30 min. The mix-
turewas centrifuged for 30min at 30,000
 g, and the pellet was
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discarded. The lysate was further clarified by adding 0.2 vol-
umes of ice-cold acetone, stirring themixture on ice for 15min,
centrifuging for 15min at 30,000
 g, and discarding the pellet.
The dehydrogenase complexes were then precipitated by
slowly adding an additional 0.4 volumes of ice-cold acetone.
The mixture was gently stirred for 30 min on ice and centri-
fuged for 30 min at 30,000
 g. The supernatant was discarded.
The precipitated proteins were dissolved in 50 ml of ice-cold
100 mM KH2PO4, pH 7.5, with 0.5 mM PMSF. Undissolved
material was removed by centrifugation for 15 min at 15,000

g. The supernatant was applied to a CHT ceramic hydroxyapa-
tite (type I, 40mparticle size) column (dimensions 2.2
 16.5
cm) at a flow rate of 2.0ml/min using anÄkta Express system at
room temperature. The column was washed with 2 column
volumes of 100 mM KH2PO4, pH 7.5. The complexes were
eluted at a flow rate of 5 ml/min using a linear gradient over 2
column volumes to 500mMKH2PO4, pH7.5, with 2-ml fraction
collection. Fractions were assayed for pyruvate and -keto-
glutarate dehydrogenase activity and pooled accordingly. The
complexes were concentrated using an Amicon ultra-centrifu-
gal filter (30-kDa cutoff) to a volume of less than 1 ml. The
complexes were further purified using gel filtration over a Sep-
hacryl S-400 column (dimensions 1.6 
 38.0 cm) run isocrati-
cally with 100 mM KH2PO4, pH 7.5, and 1 mM EDTA at 0.5
ml/min with an Äkta Purifier system at 4 °C. Fractions contain-
ing pyruvate or -ketoglutarate dehydrogenase activity were
again pooled and concentrated using an Amicon ultra-centrif-
ugal filter. Purity was assessed using an SDS-polyacrylamide gel
stained with Coomassie Blue.
PCA and Pyocyanin Reduction by Purified Proteins—Phena-
zine reduction by purified proteins was measured using a
Thermo Fisher Scientific Evolution 260 Bio-spectrophotome-
ter housed within an anaerobic chamber. PCA reduction was
followed at 440 nm at 5 Hz with an integration time of 0.2 s.
Pyocyanin reduction was followed at 690 nm at 5 or 20 Hz with
an integration time of 0.2 or 0.05 s, respectively. The extinction
coefficients used were 440 2206 M1 cm1 for reduced PCA,
440 35.4 M1 cm1 for oxidized PCA, 690 4306 M1 cm1
for oxidized pyocyanin, and 690  0 M1 cm1 for reduced
pyocyanin. PCA was dissolved to a stock concentration of 20
mM in 300 mM KH2PO4, pH 7.5. Pyocyanin was dissolved to a
stock concentration of 10mM in 20mMHCl. All reactions were
performed at 30 °C. The limit of detection was25 M, corre-
sponding to a change in absorbance of 0.01 before the rate
became non-linear.
The pyruvate and-ketoglutarate dehydrogenase complexes
were assayed using 0.5–0.9 M LpdG (as measured by flavin
content) in 50 mM KH2PO4, pH 7.5, 1 mM EDTA, 3 mMMgCl2,
200 M TPP, 200 M CoA, and 2.5 mM pyruvate or -keto-
glutarate. Where applicable, inhibitors were added from a 100

stock solution. The reaction was initiated by adding an equal
volume of a 2
 solution of phenazine.
DLDHwas assayed using 2Mprotein (asmeasured by flavin
content) in phosphate buffer, pH 7.5, with 1 mM EDTA and
1 mM NADH or 1 mM dihydrolipoamide (dissolved in 50%
isopropyl alcohol as a 100 mM stock solution). Because the
enzymes required different ionic strengths for stability, LpdG
and Lpd3 were assayed using 300 mM KH2PO4, and LpdV was
assayed using 50 mM KH2PO4. For PCA, the reaction was initi-
ated by adding an equal volume of 2
 PCA; for pyocyanin, the
reaction was initiated by adding an equal volume of 2
NADH
or dihydrolipoamide.
Fluorescence Quenching—The fluorescence of LpdG was
measured in a black half-area microtiter plate using a BioTek
Synergy 4 plate reader. Each well contained 100 l of 2 M
protein in 300 mM KH2PO4, pH 7.5, with the appropriate con-
centration of ligand. Fluorescence was measured using a tung-
sten lamp with a 485  10-nm excitation filter and a 528 
10-nm emission filter. The background fluorescence of a
control well, without protein but with the same ligand concen-
tration, was subtracted from the protein fluorescence.
Curve Fitting—Non-linear curve fitting was performed using
the curve_fit function from SciPy’s optimization package. Flu-
orescence quenching data were fit with the formula F ([S]N/
([S]N  KdN)) 
 (Fs  Fo)  Fo, where F is the observed fluo-
rescence; [S] is the substrate concentration;N is themeasure of
cooperativity (Hill coefficient); Kd is the dissociation constant;
Fs is the fluorescence at a saturating substrate concentration;
and Fo is the fluorescence in the absence of substrate. Kinetic
data were fit with the equation R Vmax[S]/(Km [S]), where
R is the rate of reaction;Vmax is themaximum reaction velocity;
[S] is the substrate concentration; and Km is the substrate con-
centration at half of Vmax.
Cloning—Heterologous expression vectors for LpdG, Lpd3,
and LpdV were prepared similarly as follows. The full ORFs
were amplified with PCR from P. aeruginosa PA14 genomic
DNA.The forward and reverse primers contained an additional
stop codon and restriction sites for cloning into the Novagen
pET-15b expression vector (Millipore, Sigma). For LpdG, the
forward primer was AGAGAGcatatgAGCCAGAAATTCGA-
CGTG, and the reverse primer was ACACACggatccTTATTA-
TCAGCGCTTCTTGCGGTT. For Lpd3, the forward primer
was AGAGAGcatatgATGGAAAGCTATGACGTGATCGTG,
and the reverse primer was ACACACggatccTTATTATCAG-
TTCTGCATGGCCCG. For LpdV, the forward primer was
AGAGAGcatatgAGCCAGATCCTGAAGACTTC, and the
reverse primer was ACACACctcgagTTATTATCAGATGTG-
CAGGGCGTG. The products for LpdG and Lpd3, and the
pET15b vector, were digestedwithNdeI andBamHI. The prod-
uct for LpdV and the pET15b vector were digested with NdeI
andXhoI. The digestswere purified using theQiagenPCRpuri-
fication kit, and the resulting ORF and plasmid products were
ligated together with T4 DNA ligase. The ligated product was
transformed into E. coli Top10 (Invitrogen) and selected for on
LB agar plates with 50 g/ml carbenicillin. Individual colonies
were culture, and the constructed plasmid was isolated using a
Qiagenminiprep kit and sequenced (Retrogen) to verify that no
mutations were introduced. The plasmidwas then transformed
into E. coli BL21(DE3) (62) for protein expression.
Site-directed mutants of LpdG were created by PCR amplifi-
cation of the LpdG-pET15b vector. The wild type vector was
amplified using primers that contained appropriate mis-
matches. The resulting PCR product was phosphorylated using
T4 polynucleotide kinase, blunt-end ligated using T4 DNA
ligase, and transformed into E. coli Top10 and BL21 as
described above. For LpdG I192G, the primers were GGCCT-
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GGAGCTGGGTTC and GCCGACGCCGGCGCCGAT. For
LpdG V191Y, the primers were ATTGGCCTGGAGCTGGGT
and ATAGCCGGCGCCGATCACAC.
Dihydrolipoamide Dehydrogenase Purification—His6-tagged
DLDH homologs and mutants were purified using the same
procedure. E. coli BL21 harboring the expression plasmid (see
under “Cloning”) was cultured at 37 °C to an A600 of 0.8 in
terrific broth containing 12 g/liter tryptone, 24 g/liter yeast
extract, 4 ml/liter glycerol, 17 mM KH2PO4, 72 mM K2HPO4, 8
mM MgSO4, and 100 g/ml ampicillin. A typical purification
used 1 liter of cells grown in a 2.8-liter baffled Fernbach flask.
All steps after culturing were performed at 4 °C. The cells were
harvested by centrifugation for 15 min at 5000 
 g. The pellet
was resuspended in 2.5 volumes of 50mMKH2PO4, pH 7.5, 200
mM KCl, 50 mM imidazole, and 1 mM PMSF. The cells were
lysed using 3–4 passes through anAvestin Emulsiflex-C3 oper-
ating at 15,000 p.s.i., and the lysate was clarified by centrifuga-
tion for 30 min at 30,000
 g. The supernatant was applied to a
5-ml HisTrap HP column (GE Healthcare) with an Äkta Puri-
fier system running at 3 ml/min. The column was washed with
5 column volumes of 50mMKH2PO4, pH 7.5, 200mMKCl, and
50 mM imidazole, and proteins were eluted using a linear gra-
dient over 5 column volumes to 50 mM KH2PO4, pH 7.5, 200
mM KCl, and 500 mM imidazole. The yellow fractions were
pooled, concentrated using an Amicon ultra-centrifugal filter
(30 kDa) to a volume of less than 3 ml, and desalted using a
HiPrep 26/10 desalting column (GE Healthcare) into a buffer
containing 300 mMKH2PO4, pH 7.5. The yellow fractions were
again pooled and stored at 4 °C. All of the preparations were at
least 95% pure as judged by Coomassie Blue staining of an SDS-
polyacrylamide gel.
For crystallography, LpdG was purified as described above
except that protein was purified from 6 liters of cell culture
using a 20-ml HisPrep FF 16/10 column (GEHealthcare). Prior
to desalting, the proteinwas incubated overnight at 4 °Cwith 50
units of thrombin (EMD Millipore). The protein was concen-
trated and desalted into 50 mM KH2PO4, pH 7.5, 500 mM KCl,
and 20 mM imidazole. Uncleaved protein, and other contami-
nants that bind to the HisPrep column, were removed by pass-
ing the protein back through the HisPrep column and collect-
ing the flow-through. The flow-through was applied to a CHT
ceramic hydroxyapatite (type I, 40 m particle size) column
(dimensions 2.2 
 16.5 cm) at a flow rate of 5.0 ml/min. The
column was washed with 2 column volumes of 100 mM
KH2PO4, pH 7.5, and highly pure LpdG was eluted using a lin-
ear gradient over 2 column volumes to 500 mM KH2PO4, pH
7.5. The yellow fractions were pooled, concentrated, and
desalted into 25 mM HEPES, pH 7.5, with 600 mM KCl, and
stored at 4 °C.
Flavoprotein concentrations were determined spectropho-
tometically. An aliquot of proteinwas first boiled in the dark for
5min. The precipitated proteinwas removed by centrifugation,
and the concentration of liberated flavin was determined using
the FAD extinction coefficient of 450 11,300 M1 cm1.
Proteomics—In-gel digests were performed as described pre-
viously (63), and LC-MS/MS analysis was performed at the
Caltech Proteome Exploration Laboratory (64).
Crystallography—Initial crystal screens were performed
using vapor diffusion in sitting drop plates. The five screens
used were Crystal Screen HT (Hampton), Index HT (Hamp-
ton), PEGRx HT (Hampton), JCSG-plus HT-96 (Molecular
Dimensions), andWizardClassic 1 and 2 (Rigaku). AnArt Rob-
ins Gryphon nano-liquid-handling robot was used tomix 0.2l
of screen solution with 0.2 l of protein solution (30 mg/ml in
25 mM HEPES, pH 7.5, with 600 mM KCl). The plates were
sealed with transparent film and incubated at 20 °C. The plates
were monitored every several days for crystal growth using a
stereoscopic microscope. For each well that formed crystals, a
secondary screen was performed using similar conditions with
a wider concentration of salt, pH, and PEG.
The optimized crystals were grown in a hanging-drop format
using Hampton VDX plates with sealant and siliconized glass
cover slides. Drops were created by mixing 1.5 l of mother
liquor with 2 l of protein solution and 0.5 l of seed solution.
Themother liquor contained 500l of 22% PEG-3350 with 530
mM HEPES, pH 6.1. The protein solution contained 6 mg/ml
LpdG (as measured by the BCA assay) in 400 mM HEPES, pH
6.1, with 100mMKCl. The seed solution contained several crys-
tals, which were crushed by vortexing with a glass bead and
diluted1000-fold, in 22% PEG-3350 with 10 mM HEPES, pH
6.5. The pH 6.1 HEPES buffers were prepared using a stock of 1
M HEPES with 50 mM MES, and so the final drop solution con-
tained 11% PEG-3350, 400 mM HEPES, 50 mM KCl, and 23 mM
MES. The initial seed crystal formed under similar conditions
at pH 7.5 and was propagated to the lower pH through several
rounds of crystallization and seeding. Crystals formed as yellow
cubes or bricks and were apparent after 5 h at pH 6.5–7.0 or
overnight at pH6.1. The best diffracting crystalswere grown for
24–48 h and were 50–100 m in each dimension.
Ligand soaking and cryoprotection were performed deli-
cately because the crystals were highly susceptible to cracking
from osmotic strength changes. Crystals were first transferred
to 8 l of mother liquor on a coverslip. Serial dilutions (2-fold)
were created of the soaking or cryo solution with the mother
liquor, and the crystals were slowly acclimated by mixing in
0.5–1 l of new solution with a pipette tip. The same volume
was removed from the drop and iteratively replaced until
Schlieren lines were no longer visible, and the process was
repeated using a higher concentration of ligand or cryopro-
tectant. Typically, batches of 10 crystals were acclimated at a
time over 30–45 min. The final cryoprotection solution con-
tained 50 mMHEPES, pH 7.0, 20% PEG-3350, 20% DMSO, and
the final desired ligand concentration. Crystals were flash-fro-
zen by plunging into liquid nitrogen.
Data collection was performed at the Stanford Synchrotron
Radiation Lightsource, beamline 12-2. Diffraction images were
collected every 0.15° for a full 360° around a single axis (2400
images total) using X-rays at 12,658 eV. Data completion was
frequently low (90%) because of the low symmetry in P21 and
the dead spaces between detector tiles of the Pilatus 6M, and so
a second dataset was collected for each crystal utilizing a detec-
tor offset of 10 mm in the X and Y directions. For well diffract-
ing crystals with minimal radiation damage, this process was
repeated with X-rays at 6900 eV to capture the anomalous sig-
nal from sulfur. The datasets were integrated with XDS (65),
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scaled together with XSCALE, and then processed with
POINTLESS (66), merged with AIMLESS (67), and converted
to structure factors with CTRUNCATE in the CCP4 suite (68).
The structure was solved by molecular replacement with
Phaser (69) using a searchmodel consisting of chain A from the
structure 1LPF in the Protein Data Bank. The structure was
refined using phenix.refine (70), and ligands (FAD and NADH)
were placed using phenix.ligandfit (71). For the structure con-
tainingNAD, a fragment of theNAD ligandwas placedman-
ually in Coot (72) because electron density was not apparent for
the full ligand. Side chains were trimmed in Coot where there
was undefined electron density. Further refinement was per-
formed with phenix.refine and iterative model building in Coot
to the resolution that provided an arbitrary signal-to-noise cut-
off of 2.0. Paired refinement (49) was then used in 0.05–0.08 Å
increments to establish the resolution limit of useful data.
Riding hydrogens considerably improved Rfree and overall
geometry and so they were included in all models. Compared
with a simpler TLS model of anisotropy, a fully anisotropic
model improved Rfree and overall geometry for the apo- and
NAD structures, and so these models were refined using
anisotropic B-factors. TLS parameters for the lower resolution
NADH structure were determined and refined with PHENIX.
A large number ofDMSOmolecules, originating from the cryo-
protectant, were placed manually in Coot with guidance from
the low-energy anomalous differencemap. The high resolution
apo-structure suggested deviations from planarity in the flavin
ring of FAD, and so the final rounds of refinement in the apo-
and NAD structures were performed using relaxed planarity
restraints for FAD.
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